FrancophonIA/ELRC3.0 huggingface dataset:
English: The hepatic safety of maraviroc in combination with other antiretroviral agents in CCR5-tropic HIV-1-infected subjects with HIV RNA <50 copies/mL, co-infected with Hepatitis C and/or Hepatitis B Virus was evaluated in a multicentre, randomized, double blinded, placebo-controlled study.
Croatian: U multicentričnom, randomiziranom, dvostruko slijepom, placebom kontroliranom ispitivanju, ispitivana je sigurnost za jetru kod primjene maraviroka u kombinaciji s drugim antiretrovirusnim lijekovima u ispitanika zaraženih CCR5-tropnim virusom HIV-1 kod kojih je HIV RNK <50 kopija/ml, a koji su istodobno zaraženi virusom hepatitisa B i/ili hepatitisa C.
English: Efavirenz 600 mg QD + saquinavir/ritonavir 1000 mg/100 mg BID (maraviroc 100 mg BID)
Croatian: Efavirenz 600 mg 1x dnevno + sakvinavir/ritonavir 1000 mg/ 100 mg 2x dnevno (maravirok 100 mg 2x dnevno)
English: The clinical status of the patient and the adverse reaction profile of maraviroc should be borne in mind when considering the patient's ability to drive, cycle or operate machinery.
Croatian: Kada se razmatra bolesnikova sposobnost upravljanja vozilom, vožnje bicikla ili rada sa strojevima, treba uzeti u obzir njegov klinički status i profil nuspojava maraviroka.
English: Subjects with a functional CYP3A5 (CYP3A5*1 allele) have been shown to have a reduced exposure to maraviroc compared to subjects with defect CYP3A5 activity (e.g., CYP3A5*3, CYP3A5*6, and CYP3A5*7).
Croatian: Pokazalo se da je izloženost maraviroku u ispitanika s funkcionalnim enzimom CYP3A5 (alel CYP3A5*1) manja nego u ispitanika sa smanjenom aktivnošću CYP3A5 (npr.
English: CELSENTRI 25 mg film-coated tablets
Croatian: CELSENTRI 25 mg filmom obložene tablete
English: Study A4001029 was an exploratory study in patients infected with dual/mixed or CXCR4 tropic HIV-1 with a similar design as the studies MOTIVATE 1 and MOTIVATE 2.
Croatian: Ispitivanje A4001029 bilo je eksploratorno ispitivanje u bolesnika zaraženih dvostruko/miješanim ili CXCR4 tropnim HIV-1, dizajna sličnog ispitivanjima MOTIVATE 1 i MOTIVATE 2. U tih ispitanika primjena maraviroka nije bila povezana sa značajnim smanjenjem vrijednosti HIV-1 RNK u odnosu na placebo i nije primijećen negativan učinak na broj CD4+ stanica.
English: CELSENTRI 150 mg film-coated tablets
Croatian: CELSENTRI 150 mg filmom obložene tablete
English: Metabolism and nutrition disorders Anorexia common
Croatian: Poremećaji metabolizma i prehrane
English: CELSENTRI dose should be decreased to 150 mg twice daily when co-administered with ketoconazole.
Croatian: Dozu lijeka CELSENTRI treba smanjiti na 150 mg 2x dnevno kada se primjenjuje istodobno s ketokonazolom.
English: CELSENTRI dose should be increased to 600 mg twice daily when coadministered with carbamazepine, phenobarbital or phenytoin in the absence of a potent CYP3A4 inhibitor.
Croatian: Dozu lijeka CELSENTRI treba povećati na 600 mg 2x dnevno kada se primjenjuje istodobno s karbamazepinom, fenobarbitalom ili fenitoinom, a bez snažnog inhibitora CYP3A4.
English: Atazanavir concentrations not measured, no effect is expected.
Croatian: Koncentracije atazanavira nisu određivane, učinak nije očekivan.
English: boceprevir, telaprevir)
Croatian: nelfinavir, ritonavir, sakvinavir, boceprevir, telaprevir)
English: Excipient with known effect: each 75 mg film-coated tablet contains 0.42 mg of soya lecithin.
Croatian: Pomoćna tvar s poznatim učinkom: jedna filmom obložena tableta od 75 mg sadrži 0,42 mg sojinog lecitina.
English: Tipranavir/ritonavir 500 mg/200 mg BID (maraviroc 150 mg BID)
Croatian: Tipranavir/ritonavir 500 mg/200 mg 2x dnevno (maravirok 150 mg 2x dnevno)
English: 2x carton for blister pack containing 300 mg maraviroc film-coated tablets - without Blue Box
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU 2x kutija za blister pakiranja koja sadrži filmom obložene tablete od 300 mg maraviroka - bez plavog okvira
English: CELSENTRI dose should be increased to 600 mg twice daily when co-administered with rifampicin in the absence of a potent CYP3A4 inhibitor.
Croatian: Dozu lijeka CELSENTRI treba povećati na 600 mg 2x dnevno kad se primjenjuje istodobno s rifampicinom bez prisustva snažnih CYP3A4 inhibitora.
English: Blue, biconvex, oval film-coated tablets, approximate dimensions 8.56 mm x 15.5 mm and debossed with “MVC 150”.
Croatian: Plave, bikonveksne, ovalne filmom obložene tablete približnih dimenzija 8,56 mm x 15,5 mm, sutisnutom oznakom „MVC 150“.
English: Maraviroc 300 mg twice daily + OBT N=426
Croatian: Maravirok 300 mg 2x dnevno +OBT N = 426
English: CELSENTRI dose should be decreased to 150 mg twice daily when co-administered with clarithromycin and telithromycin.
Croatian: Dozu lijeka CELSENTRI treba smanjiti na 150 mg 2x dnevno kad se primjenjuje istodobno s klaritromicinom ili telitromicinom.
English: Each film-coated tablet contains 75 mg of maraviroc.
Croatian: Jedna filmom obložena tableta sadrži 75 mg maraviroka.
English: Each film-coated tablet contains 300 mg of maraviroc.
Croatian: Jedna filmom obložena tableta sadrži 300 mg maraviroka.
English: 2x carton for blister pack containing 150 mg maraviroc film-coated tablets - without Blue Box
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU 2x kutija za blister pakiranja koja sadrži filmom obložene tablete od 150 mg maraviroka - bez plavog okvira
English: Efavirenz concentrations not measured, no effect is expected.
Croatian: Koncentracije efavirenza nisu određivane, učinak nije očekivan.
English: Blue, biconvex, oval film-coated tablets, approximate dimensions 6.74 mm x 12.2 mm and debossed with “MVC 75”.
Croatian: Plave, bikonveksne, ovalne filmom obložene tablete približnih dimenzija 6,74 mm x 12,2 mm, s utisnutom oznakom „MVC 75“.
English: Maraviroc Cmax: ↑ 1.25
Croatian: Maravirok Cmax:  1,25
English: Midazolam 7.5 mg Single Dose (maraviroc 300 mg BID)
Croatian: Midazolam 7,5 mg jednokratna doza (maravirok 300 mg 2x dnevno)
English: Protease Inhibitors (PIs) Atazanavir 400 mg QD (maraviroc 300 mg BID)
Croatian: Inhibitori proteaze (IP) Atazanavir 400 mg 1x dnevno (maravirok 300 mg 2x dnevno)
English: CELSENTRI 20 mg/ml oral solution
Croatian: NAZIV LIJEKA CELSENTRI 20 mg/ml oralna otopina
English: Anti-HCV Ribavirin
Croatian: Lijekovi za hepatitis C Ribavirin
English: Blue, biconvex, oval film-coated tablets, approximate dimensions 10.5 mm x 19.0 mm and debossed with “MVC 300”.
Croatian: Plave, bikonveksne, ovalne filmom obložene tablete približnih dimenzija 10,5 mm x 19,0 mm, s utisnutom oznakom „MVC 300“.
English: Maraviroc concentrations not measured, no effect is expected.
Croatian: Koncentracije maraviroka nisu određivane, učinak nije očekivan.
English: Maraviroc Cmax: ↑ 4.78
Croatian: Maravirok Cmax:  4,78
English: Maraviroc AUC12: ↑ 2.53
Croatian: Maravirok AUC12:  2,53
English: Discontinue maraviroc and other suspect agents immediately if signs or symptoms of severe skin or hypersensitivity reactions develop.
Croatian: Ako se pojave znakovi ili simptomi teških kožnih reakcija ili reakcija preosjetljivosti, odmah prekinite primjenu maraviroka i drugih suspektnih lijekova.
English: Maraviroc AUC12: ↓ 0.55
Croatian: Maravirok AUC12:  0,55
English: Gastrointestinal disorders Amylase
Croatian: Poremećaji probavnog sustava Amilaza
English: Atazanavir/ritonavir concentrations not measured, no effect is expected.
Croatian: Koncentracije atazanavira/ritonavira nisu određivane, učinak nije očekivan.
English: ANTIFUNGALS Ketoconazole 400 mg QD (maraviroc 100 mg BID)
Croatian: ANTIMIKOTICI Ketokonazol 400 mg 1x dnevno (maravirok 100 mg 2x dnevno)
English: Serious side effects - get medical help immediately Serious allergic or skin reactions
Croatian: Ozbiljne nuspojave - odmah potražite liječničku pomoć
English: • skin rash or itching
Croatian: • kožni osip ili svrbež
English: Excipient with known effect: each 150 mg film-coated tablet contains 0.84 mg of soya lecithin.
Croatian: Pomoćna tvar s poznatim učinkom: jedna filmom obložena tableta od 150 mg sadrži 0,84 mg sojinog lecitina.
English: 50 mg twice daily
Croatian: 50 mg dva puta na dan
English: Excipient with known effect: each 25 mg film-coated tablet contains 0.14 mg of soya lecithin.
Croatian: Pomoćna tvar s poznatim učinkom: jedna filmom obložena tableta od 25 mg sadrži 0,14 mg sojinog lecitina.
English: Tenofovir concentrations not measured, no effect is expected.
Croatian: Koncentracije tenofovira nisu određivane, učinak nije očekivan.
English: Each film-coated tablet contains 25 mg of maraviroc.
Croatian: Jedna filmom obložena tableta sadrži 25 mg maraviroka.
English: Tenofovir 300 mg QD (maraviroc 300 mg BID)
Croatian: Tenofovir 300 mg 1x dnevno (maravirok 300 mg 2x dnevno)
English: 120 film-coated tablets
Croatian: 60 filmom obloženih tableta
English: 300 mg twice daily
Croatian: 300 mg dva puta na dan
English: Antiretrovirals
Croatian: ANTIKONVULZIVI
English: celsentri 20 mg/ml
Croatian: 16. PODACI NA BRAILLEOVOM PISMU celsentri 20 mg/ml
English: Maraviroc Cmax: ↑ 2.29
Croatian: Maravirok Cmax:  2,29
English: Atazanavir/ritonavir 300 mg/100 mg QD (maraviroc 300 mg BID)
Croatian: Atazanavir/ritonavir 300 mg/100 mg 1x dnevno (maravirok 300 mg 2x dnevno)
English: 100 mg twice daily
Croatian: 100 mg dva puta na dan
English: Maraviroc Cmax: ↑ 2.67
Croatian: Maravirok Cmax:  2,67
English: Darunavir/ritonavir 600 mg/100 mg BID (maraviroc 150 mg BID)
Croatian: Darunavir/ritonavir 600 mg/100 mg 2x dnevno (maravirok 150 mg 2x dnevno)
English: Zidovudine Cmax: ↔ 0.92
Croatian: Zidovudin Cmax:  0,92
English: Maraviroc was not mutagenic or genotoxic in a battery of in vitro and in vivo assays including bacterial reverse mutation, chromosome aberrations in human lymphocytes and mouse bone marrow micronucleus.
Croatian: Brojni in vitro i in vivo testovi (uključujući reverznu mutaciju bakterija, kromosomske aberacije u limfocitima čovjeka i mikronukleus koštane srži miša) nisu pokazali postojanje mutagenosti kao niti genotoksičnosti maraviroka.
English: Maraviroc Cmax: ↑ 2.26
Croatian: Maravirok Cmax:  2,26
English: Maraviroc Cmax: ↔ 0.86
Croatian: Maravirok Cmax:  0,86
English: CELSENTRI 300 mg twice daily should be administered with caution when co-administered with fluconazole.
Croatian: Doza lijeka CELSENTRI je 300 mg 2x dnevno kod istodobne primjene s flukonazolom uz pojačani oprez.
English: Zidovudine AUC12: ↔ 0.98
Croatian: Levonorgestrel AUC12:  0,98
English: Rifampicin 600 mg QD (maraviroc 100 mg BID)
Croatian: Rifampicin 600 mg 1x dnevno (maravirok 100 mg 2x dnevno)
English: Each film-coated tablet contains 150 mg of maraviroc.
Croatian: Jedna filmom obložena tableta sadrži 150 mg maraviroka.
English: Blue, biconvex, oval film-coated tablets, approximate dimensions 4.6 mm x 8.0 mm and debossed with “MVC 25”.
Croatian: Plave, bikonveksne, ovalne filmom obložene tablete približnih dimenzija 4,6 mm x 8,0 mm, s utisnutom oznakom „MVC 25“.
English: CELSENTRI 300 mg twice daily and sulphamethoxazole/ trimethoprim can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i sulfametoksazol/trimetoprim mogu se istodobno primijeniti bez prilagođavanja doze.
English: Maraviroc Cmax: ↑ 2.09
Croatian: Maravirok Cmax:  2,09
English: Maraviroc Cmax: ↔ 1.19
Croatian: Maravirok Cmax:  1,19
English: Maraviroc AUC12 ↔ 1.02
Croatian: Maravirok AUC12:  1,02
English: Studies in Treatment-Experienced Paediatric Patients Infected with CCR5-tropic Virus
Croatian: Ispitivanja u prethodno liječenih pedijatrijskih bolesnika zaraženih CCR5-tropnim virusom
English: Each ml of oral solution contains 20 mg maraviroc.
Croatian: 2. NAVOĐENJE DJELATNE(IH) TVARI Jedan ml oralne otopine sadrži 20 mg maraviroka.
English: Raltegravir 400 mg BID (maraviroc 300 mg BID)
Croatian: Raltegravir 400 mg 2x dnevno (maravirok 300 mg 2x dnevno)
English: Laboratory abnormalities
Croatian: Laboratorijska patološka odstupanja
English: Lopinavir/ritonavir concentrations not measured, no effect is expected.
Croatian: Koncentracije lopinavira/ritonavira nisu određivane, učinak nije očekivan.
English: CELSENTRI 75 mg film-coated tablets maraviroc
Croatian: NAZIV LIJEKA CELSENTRI 75 mg filmom obložene tablete maravirok
English: CELSENTRI dose should be decreased to 150 mg twice daily when co-administered with etravirine and a PI.
Croatian: Doza lijeka CELSENTRI se mora smanjiti na 150 mg dva puta na dan kad se primjenjuje istodobno s etravirinom, u prisutnosti IP.
English: Maraviroc Cmax: ↑ 1.97
Croatian: Maravirok Cmax:  1,97
English: CELSENTRI dose should be decreased to 150 mg twice daily when co-administered with itraconazole.
Croatian: Dozu lijeka CELSENTRI treba smanjiti na 150 mg 2x dnevno kod istodobne primjene s itrakonazolom.
English: Ethinylestradiol 30 mcg QD (maraviroc 100 mg BID)
Croatian: Etinilestradiol 30 mcg 1x dnevno (maravirok 100 mg 2x dnevno)
English: CELSENTRI 300 mg twice daily and raltegravir can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg dva puta na dan i raltegravir mogu se primjenjivati istodobno bez prilagođavanja doze.
English: Etravirine 200 mg BID (maraviroc 300 mg BID)
Croatian: Etravirin 200 mg 2x dnevno (maravirok 300 mg 2x dnevno)
English: celsentri 75 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU celsentri 75 mg
English: AUC: ↔ 1.18 Midazolam.
Croatian: AUC:  1,18
English: Studies in Treatment-Experienced Adult Patients Infected with Non-CCR5-tropic Virus
Croatian: Ispitivanja u prethodno liječenih odraslih bolesnika zaraženih virusima koji nisu CCR5-tropni
English: Studies in Treatment-Experienced Adult Patients Infected with CCR5-tropic Virus
Croatian: Ispitivanja u prethodno liječenih odraslih bolesnika zaraženih CCR5-tropnim virusom
English: Lopinavir/ritonavir 400 mg/100 mg BID (maraviroc 300 mg BID)
Croatian: Lopinavir/ritonavir 400 mg/100 mg 2x dnevno (maravirok 300 mg 2x dnevno)
English: The adverse reactions and laboratory abnormalities presented below are not exposure adjusted.
Croatian: Prilikom procjene nuspojava i patoloških laboratorijskih nalaza navedenih u tablicama nisu u obzir uzimane doze lijeka kojima su bolesnici bili izloženi.
English: Efavirenz, saquinavir/ritonavir concentrations not measured, no effect expected.
Croatian: Koncentracije efavirenza, sakvinavira/ritonavira nisu određivane, učinak nije očekivan.
English: CELSENTRI 300 mg twice daily and digoxin can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i digoksin mogu se istodobno primijeniti bez prilagodbe doze.
English: Anaemia common
Croatian: Anemija često
English: Fosamprenavir/ritonavir 700 mg/100 mg BID (maraviroc 300 mg BID)
Croatian: Fosamprenavir/ritonavir 700 mg/100 mg 2x dnevno (maravirok 300 mg 2x dnevno)
English: Efavirenz, lopinavir/ritonavir concentrations not measured, no effect expected.
Croatian: Koncentracije efavirenza, lopinavira/ritonavira nisu određivane, učinak nije očekivan.
English: Concomitant use of maraviroc and St. John's Wort or products containing St. John's Wort is not recommended.
Croatian: Ne preporučuje se istodobna primjena maraviroka i gospine trave ili proizvoda koji sadrže gospinu travu.
English: Maraviroc Cmax: ↓ 0.34
Croatian: Maravirok Cmax:  0,34
English: Package leaflet: information for the user CELSENTRI 20 mg /ml oral solution maraviroc
Croatian: NAZIV LIJEKA CELSENTRI 20 mg/ml oralna otopina maravirok
English: Maraviroc AUC12 ↑ 4.88
Croatian: Maravirok AUC12:  4,88
English: Saquinavir/ritonavir 1000 mg/100 mg BID (maraviroc 100 mg BID)
Croatian: sakvinavir/ritonavir 1000 mg/ 100 mg 2x dnevno (maravirok 100 mg 2x dnevno)
English: Tel: + 420 222 001 111 cz.info@gsk.com
Croatian: Česká republika GlaxoSmithKline s.r.o. Tel: + 420 222 001 111 cz.info@gsk.com
English: 180 film-coated tablets
Croatian: 4. FARMACEUTSKI OBLIK I SADRŽAJ 180 filmom obloženih tableta
English: Liver problems
Croatian: Česte nuspojave
English: Maraviroc Cmax: ↑ 3.38
Croatian: Maravirok Cmax:  3,38
English: Your doctor must take blood samples to test whether CELSENTRI is an appropriate treatment for you (or your child, if they are the patient).
Croatian: Da bi procijenio je li CELSENTRI primjeren lijek za Vas (ili Vaše dijete, ako je ono bolesno), liječnik će Vam morati uzeti uzorak krvi.
English:  chest pain (caused by reduced blood flow to the heart)  decrease in muscle size  some types of cancer, such as of the gullet (oesophagus) and bile duct  decrease in number of blood cells (seen in blood test results).
Croatian: • bol u prsnom košu (uzrokovana smanjenim protokom krvi prema srcu)
English: diarrhoea, fatigue and headache.
Croatian: Bol u zglobovima, ukočenost i tegobe s kostima
English: 30 film-coated tablets 60 film-coated tablets 90 film-coated tablets
Croatian: 4. FARMACEUTSKI OBLIK I SADRŽAJ 90 filmom obloženih tableta.
English:  feeling dizzy, faint or light headed when standing up  kidney failure, protein in the urine
Croatian: • omaglica, nesvjestica ili ošamućenost pri ustajanju
English: Rare side effects These may affect up to 1 in 1,000 people:
Croatian: Mogu se javiti u do 1 na 1000 bolesnika:
English: • stomach pain or tenderness
Croatian: • bol ili osjetljivost u trbuhu
English: CELSENTRI 25 mg film-coated tablets maraviroc
Croatian: NAZIV LIJEKA CELSENTRI 25 mg filmom obložene tablete maravirok
English: Maraviroc AUC12 ↑ 9.77
Croatian: Maravirok AUC12:  9,77
English: CELSENTRI 300 mg twice daily and methadone can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i metadon se mogu istodobno primijeniti bez prilagodbe doze.
English: Virologic Escape
Croatian: Virusna rezistencija
English: Maraviroc Cmax: ↓ 0.49
Croatian: Maravirok Cmax:  0,49
English: Elvitegravir/ritonavir 150/100mg QD (maraviroc 150 mg BID)
Croatian: Inhibitori integraze Elvitegravir/ritonavir 150/100 mg 1x dnevno (maravirok 150 mg 2x dnevno)
English: Saquinavir/ritonavir concentrations not measured, no effect is expected.
Croatian: Koncentracije sakvinavira/ritonavira nisu određivane, učinak nije očekivan.
English: Carton for bottles containing 75 mg maraviroc film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za bocu koja sadrži maravirok 75 mg filmom obložene tablete
English: Joint pain, stiffness and bone problems
Croatian: • bol u zglobovima, ukočenost i tegobe s kostima
English: celsentri 300 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU celsentri 300 mg
English: Carton for bottle containing 25 mg maraviroc film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za bocu koja sadrži maravirok 25 mg filmom obložene tablete
English: Recommendations concerning coadministration in adults
Croatian: Preporuke pri istodobnoj primjeni s drugim lijekovima u odraslih
English: Reporting of side effects
Croatian: Učinci na koncentraciju djelatne tvari
English: CELSENTRI 300 mg twice daily and midazolam can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i midazolam se mogu istodobno primijeniti bez prilagođavanja doze.
English: CELSENTRI dose should be increased to 600 mg twice daily when co-administered with efavirenz in the absence of a potent CYP3A4 inhibitor.
Croatian: Dozu lijeka CELSENTRI treba povisiti na 600 mg 2x dnevno kada se primjenjuje istodobno s efavirenzom, a bez IP ili drugih snažnih inhibitora CYP3A4.
English: Etravirine Cmax: ↔ 1.08
Croatian: Etravirin Cmax 1,08 Etravirin C12  0,81
English: Maraviroc AUC12: ↓ 0.47
Croatian: Maravirok AUC12:  4,05
English: Celsentri 150 mg film-coated tablets maraviroc
Croatian: NAZIV LIJEKA CELSENTRI 150 mg filmom obložene tablete maravirok
English: CELSENTRI 300 mg film-coated tablets maraviroc
Croatian: NAZIV LIJEKA CELSENTRI 300 mg filmom obložene tablete maravirok
English: Celsentri 300 mg film-coated tablets maraviroc
Croatian: NAZIV LIJEKA Celsentri 300 mg filmom obložene tablete maravirok
English: CELSENTRI 300 mg twice daily and buprenorphine can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i buprenorfin se mogu istodobno primijeniti bez prilagodbe doze.
English: Pneumonia, oesophageal candidiasis uncommon
Croatian: Pneumonija, ezofagealna kandidijaza manje često
English: Bottle label - 75 mg film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU Naljepnica na boci - 75 mg filmom obložene tablete
English: celsentri 25 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU celsentri 25 mg
English: ANTI-INFECTIVES
Croatian: • plućna infekcija
English: Bottle label - 25 mg film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU Naljepnica na boci - 25 mg filmom obložene tablete
English: CELSENTRI 300 mg twice daily and pegylated interferon can be co-administered without dose adjustment.
Croatian: Moguće je istodobno primijeniti CELSENTRI 300 mg 2x dnevno i pegilirani interferon bez prilagodbe doze.
English: CELSENTRI 300 mg twice daily and levonorgestrel can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i levonorgestrel se mogu istodobno primijeniti bez prilagođavanja doze.
English: CELSENTRI 300 mg twice daily and statins can be co-administered without dose adjustment.
Croatian: CELSENTRI 300 mg 2x dnevno i statini se mogu istodobno primijeniti bez prilagođavanja doze.
English: Your doctor will decide the correct dose of CELSENTRI based on weight and on other medicines being taken at the same time.
Croatian: Adolescenti i djeca od navršene 2 godine i tjelesne težine od najmanje 10 kg Liječnik će odrediti točnu dozu lijeka CELSENTRI na temelju tjelesne težine i drugih lijekova koji se istodobno primjenjuju.
English: Symptoms may include:  muscle weakness  weakness beginning in the hands and feet and moving up towards the trunk of the body  palpitations or tremor  hyperactivity (excessive restlessness and movement).
Croatian: • slabost koja počinje u šakama i stopalima i širi se prema trupu
English: celsentri 150 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU celsentri 150 mg
English: Carton for bottles containing 300 mg maraviroc film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za bocu koja sadrži maravirok 300 mg filmom obložene tablete
English: CELSENTRI 300 mg twice daily and ribavirin can be co-administered without dose adjustment.
Croatian: Moguće je istodobno primijeniti CELSENTRI 300 mg 2x dnevno i ribavirin bez prilagodbe doze.
English: Bottle label - 300 mg film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU Naljepnica na boci - 300 mg filmom obložene tablete
English: Carton for bottles containing 150 mg maraviroc film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za bocu koja sadrži maravirok 150 mg filmom obložene tablete
English: Rifampicin concentrations not measured, no effect expected.
Croatian: Koncentracije rifampicina nisu određivane, učinak nije očekivan.
English: Carton for blister pack containing 300 mg maraviroc film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za blister pakiranja koja sadrži filmom obložene tablete od 300 mg maraviroka
English: Bottle label - 150 mg film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU Naljepnica na boci - 150 mg filmom obložene tablete
English: Carton for blister pack containing 150 mg maraviroc film-coated tablets
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za blister pakiranja koja sadrži filmom obložene tablete od 150 mg maraviroka
English: Maraviroc AUC12 ↑ 3.95
Croatian: Maravirok AUC12:  3,95
English: Cmax: ↔ 1.04
Croatian: Digoksin: Cmax:  1,04
English: Mean change from baseline (log copies/mL) Percentage of patients with HIV-1 RNA <400 copies/mL
Croatian: Postotak bolesnika s HIV-1 RNA  400 kopija/ml
English: Do not open them.
Croatian: Nemojte ih otvarati.
English: Number of subjects at risk Month
Croatian: Broj ispitanika pod rizikom Mjesec
English: Tell your doctor if any of these affect you.
Croatian: Obavijestite svog liječnika ako se bilo što od ovoga odnosi na Vas.
English: The secondary objectives were to compare overall response rate (ORR) and overall survival (OS).
Croatian: Sekundarni ciljevi su bili usporediti ukupnu stopu odgovora (ORR) i ukupno preživljenje (OS).